Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Shared on01 May 25
Fair value Decreased 4.68%

Shared on24 Apr 25
Fair value Decreased 4.44%

AnalystConsensusTarget has increased shares outstanding growth rate from 0.1% to 0.1%.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 9.78%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25

Upcoming FDA Approval Will Enable Needle-Free Epinephrine Adoption

Shared on01 May 25Fair value Decreased 4.68%

Shared on24 Apr 25Fair value Decreased 4.44%

Shared on17 Apr 25

Shared on09 Apr 25Fair value Increased 9.78%

Shared on02 Apr 25

Shared on01 May 25
Fair value Decreased 4.68%

Shared on24 Apr 25
Fair value Decreased 4.44%

Shared on09 Apr 25
Fair value Increased 9.78%